Econotherapeutics.
A program that represents the efforts of a hospital pharmacy management company to control drug costs is described. The program, Econotherapeutics, was developed in response to a changed health care reimbursement system that focused on the costs of products rather than the revenue generated by these products. For antimicrobial agents, a hospital-specific antibiogram is used to encourage cost-effective prescribing. A pharmacist intervention program, medical staff presentations, drug usage evaluation, management systems, and educational programs for pharmacists are all essential parts of the program. Centralized data gathering has allowed cost comparison of specific antimicrobial agents so that differences between variable cost estimates and costs based on actual use can be evaluated. Actual dose and dosage interval were used to calculate average cost per treatment day in a 121-hospital sample. Our cost data support the choice of cefotaxime over ceftriaxone.
Roark
M K
MK
Owen Healthcare, Inc., Houston, TX 77036, USA.
Reed
W E
WE
D000900:Anti-Bacterial Agents / Q000191:economics* / Q000627:therapeutic use; D003142:Communication; D003284:Contract Services / Q000191:economics; D003363:Cost Control / Q000379:methods; D003365:Costs and Cost Analysis / Q000379:methods; D016527:Drug Costs; D017723:Drug Utilization Review / Q000191:economics; D017850:Economics, Pharmaceutical; D005572:Formularies, Hospital as Topic / Q000592:standards*; D006801:Humans; D007400:Interprofessional Relations; D010607:Pharmacy Service, Hospital / Q000191:economics* / Q000458:organization & administration; D014481:United States
D000900:Anti-Bacterial Agents